
Boston Globe
<img alt="" height="1" width="1" />
Genzyme says FDA takes enforcement action at plant
Reuters
BOSTON (Reuters) - Genzyme Corp (GENZ.O) said the US government will take enforcement action and likely impose fees on the company to ensure that drugs made at its Allston Landing plant meet manufacturing standards, sending its shares down 5 percent. ...
Genzyme Says FDA Will Oversee Its FactoryNew York Times
Genzyme faces FDA enforcement over plant issuesThe Associated Press
Icahn's Genzyme Proxy Fight Helped by New FDA Plant InspectionBusinessWeek
Wall Street Journal -DailyFinance -Thompson.com
all 186 news articles »
More...